Načítá se...
Predicting clinical outcomes in neuroblastoma with genomic data integration
BACKGROUND: Neuroblastoma is a heterogeneous disease with diverse clinical outcomes. Current risk group models require improvement as patients within the same risk group can still show variable prognosis. Recently collected genome-wide datasets provide opportunities to infer neuroblastoma subtypes i...
Uloženo v:
| Vydáno v: | Biol Direct |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889397/ https://ncbi.nlm.nih.gov/pubmed/30621745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13062-018-0223-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|